17 DHC 2025

22 - 24 January 2025
Wednesday 22 January
Athene B/C (Dutch spoken)
09:15 - 10:45
Educational Radiotherapie nieuwste inzichten bij hematologie
09:15 - 09:30
Inleiding
09:30 - 10:00
Nieuwste inzichten
10:15 - 10:45
Tips en Tricks radiotherapie bij hematologie
Foyer 2
09:15 - 10:45
Clinical Abstracts (1)

Moderators:

Astrid Pulles

Canan Alhan

09:15 - 09:30
1221: Role of second autologous stem cell transplantation in relapsed multiple myeloma
Speaker:
Koen Klomberg
09:30 - 09:45
1320: Quality of life in RR CLL after MRD-guided treatment with ibrutinib + venetoclax
Speaker:
Laura Eurelings
09:45 - 10:00
1225: Allogeneic stem cell transplantation effective after pathway inhibitor treatments in CLL.

Speaker:

Michel van Gelder

10:00 - 10:15
1223: Thrombosis incidence in three multiple myeloma HOVON trials

Speaker:

Catalina Codresnu

10:15 - 10:30
1239: Mitapivat in Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II
Speaker:
Thomas Doeven
10:30 - 10:45
1299: Adaptive Designs in Randomized Clinical Trials: Reanalysis of the HOVON-87/NMSG18 MM trial
Speaker:
Maarten Seefat
Room 4/5
09:15 - 10:15
Meet the Expert Basaal (1)
09:15 - 10:15
Clonal dynamics
Room 6/7
09:15 - 10:45
Immunology Abstracts (1)
09:15 - 09:30
1240: NK cell profile predicts MRD-negativity in MM

Speaker:

Charlotte Korst

09:30 - 09:45
1257: Overcoming immune escape in TCR therapy for multiple myeloma by engineering NK cells

Speaker:

Els van Hees

09:45 - 10:00
1241: Overcoming PGE2-mediated suppression of stem cell-derived NK cells’ anti-tumor functionali

Speaker:

Marcos Vidal Manrique

10:00 - 10:15
1296: Anti-Her2-CAR CD38 gen locus knock-in enhance the persistence CAR expression and augment t

Speaker:

Ying Gong

10:15 - 10:30
1265: Anti-Her2-CAR-NK cells show earlier, enhanced cytotoxicity on HER2+ breast cancer cells

Speaker:

Meric Birben

10:30 - 10:45
1298: BCG Priming of Natural Killer Cells: Enhancing Treatment-Free Remission in CML Patients

Speaker:

Ayla Grotens

Room 8/9
09:15 - 10:45
Lymphoid Abstracts (1)
09:15 - 09:30
1236: Loss-of-adhesion CRISPR screen identifies ILK as a key regulator of adhesion in WM and MM
Speaker:
Fangxue Ma
09:30 - 09:45
1278: miR-29c-3p in CLL
Speaker:
Mischa Vervoordeldonk
09:45 - 10:00
1202: The Fat Connection: Adipocyte Progenitors and Leukemia
Speaker:
Mauricio Ferrao Blanco
10:00 - 10:15
1310: iPSC-derived osteoclasts to model MM bone disease
Speaker:
Jiaxian Wang
10:15 - 10:30
1315: induce mesenchymal stroma cells as a tool
Speaker:
Alejandro Holtmann
10:30 - 10:45
1302: 3D CLL model as a platform for AI-driven image analysis and integrative drug screening
Speaker:
Marco Haselager
Foyer
10:45 - 11:00
Pauze
Athene B/C (Dutch spoken)
11:00 - 12:00
How to treat - Nieuwe richtlijn MCL
11:00 - 11:30
Titel volgt nog

Spreker: 

Dr. Tom van Meerten

11:30 - 12:00
Titel volgt nog

Spreker:

Dr. Jeanette Doorduijn

Foyer 2 (Dutch spoken)
11:00 - 12:00
Tips en Tricks; Palliatieve zorg

Moderators:

Prof. dr. Yvette van der Linden
Dr. Evelien Kuip

11:00 - 12:00
Hoe integreer je palliatieve zorg in de hematologie? Tips en Tricks

Sprekers:

Prof. dr. Yvette van der Linden,

Dr. Evelien Kuip,

Dr. Caroline Mandigers

Room 4/5
11:00 - 12:00
Meet the Expert Basaal (2)

Moderator:

Dr. Mirjam Belderbos

11:00 - 12:00
Single cell technology and Bio  informatics
Speaker:
Dr. Mathijs Sanders
Room 6/7
11:00 - 12:00
Immunology Abstracts (2)
11:00 - 11:15
1266: Immunometabolic Profiling Uncovers Mitochondrial Drivers of T Cell Dysfunction in CLL

Speaker:

Nienke Goedhart

11:15 - 11:30
1314: Immune-aging predicts clinical outcomes in elderly multiple myeloma

Speaker:

Febe Smits

11:30 - 11:45
1211: Immune Reconstitution after Matched Sibling Donor Transplantation for Sickle Cell Disease

Speaker:

Lisa Dovern

11:45 - 12:00
1297: Characterization of T cells after allo-SCT

Speaker:

Anniek Stuut

Room 8/9 (Dutch spoken)
11:00 - 12:00
Meet the Expert klinisch (1)
11:00 - 12:00
PTLD nieuwe middelen

Spreker:

Drs. Pim Mutsaers MD

Foyer
12:00 - 13:15
Lunch en werkgroepvergaderingen
Athene B/C (Dutch spoken)
13:15 - 14:45
Educational Nieuwe richtlijn Mastocytose

Moderators:

Dr. Paul van Daele

Dr. Floor Heubel-Moenen

Dr. Saskia Klein

13:15 - 13:45
Inleiding tot Mastocytose: een overzicht.

Spreker:

Dr. Saskia Klein

13:45 - 14:15
Navigeren door HaT, MCAS en indolente mastocytose.

Spreker:

Dr. Paul van Daele

14:15 - 14:45
Advanced Mastocytose: nieuwe behandelingen.

Spreker:

Dr. Floor Heubel-Moenen

Foyer 2 (Dutch spoken)
13:15 - 14:45
Educational Werkgeluk & Werkdruk

Moderator:

Dr. Ilse Kuipers

13:15 - 13:45
Introductie kennisbank

Spreker: 

Dr. Ellen van der Spek

13:45 - 14:15
Challenge your growth – bevlogen hematologen nu en in de toekomst

Spreker:

Dr. Anne de Pagter

14:15 - 14:45
Nationale eensgezindheid?

Sprekers:

Dr. Ilse Verpoorte

Drs. Eva Hesius

Drs. Kaz Groen

Room 4/5
13:15 - 14:45
Clinical Abstracts (2)

Moderators:

Bas Blok

Hilde Kooistra

13:15 - 13:30
1262: Lenalidomide-Dexamethasone with or without Carfilzomib in High-Risk Smoldering MM
Speaker:
Annemiek Broijl
13:30 - 13:45
1226: Outcome of DLI-based strategy in relapsed AML after allogeneic stem cell transplantation
Speaker:
Jule Bergsma
13:45 - 14:00
1287: CAR-T Cell Therapy in Older Adults
Speaker:
Tara Lorjé
14:00 - 14:15
1232: Monitoring multiple myeloma treatments in the Netherlands
Speaker:
Nicole Blijlevens
14:15 - 14:30
1212: Changes in the QoL of Adults with SCD after HSCT
Speaker:
Elisabeth Dovern
14:30 - 14:45
1200: Highly Conformal Total Body Irradiation; new techniques
Speaker:
Bianca Hoeben
Room 6/7
13:15 - 14:45
Lymphoid Abstracts (2)
13:15 - 13:30
1235: Oncogenic CARD11 mutations and autonomous BCR signaling as functionally equivalent alterna
Speaker:
Janneke Eken
13:30 - 13:45
1215: Epi-drugging of DLBCL
Speaker:
Camiel Göbel
13:45 - 14:00
1277: NOTCH1 gene fusions in T-LBL
Speaker:
Emma Kroeze
14:00 - 14:15
1316: MYC Expression in Multiple Myeloma cells is Regulated by Glutamine Availability
Speaker:
Yuxin Li
14:15 - 14:30
1263: Exploring the metabolic requirements for CLL proliferation
Speaker:
Helga Simon-Molas
14:30 - 14:45
1252: Targeting Cholesterol Biosynthesis Sensitizes DLBCL Non-Responsive to EZH2 Inhibition
Speaker:
Rachele Niccolai
Room 8/9
13:15 - 14:45
Myeloid Abstracts (1)

Moderators:

 

13:15 - 13:30
1272: Double mutant DNMT3A AML: a unique subtype
Speaker:
Sanne Massaar
13:30 - 13:45
1264: Splice-Transcript Isoforms in AML
Speaker:
Ramin Shirali Hossein Zade
13:45 - 14:00
1249: Macrophages in pediatric AML
Speaker:
Alicia Perzolli
14:00 - 14:15
1251: GPR124 regulates lipid metabolism and is involved in lineage commitment in AML development
Speaker:
Manolis Kyrloglou
14:15 - 14:30
1290: Role of DNAJB6b in MN1-driven AML
Speaker:
Diego Pereira-Martins
14:30 - 14:45
1306: Uncovering dynamic interactors of oncofusion proteins in AML with proximity labelling
Speaker:
Inge de Krijger
Foyer
14:45 - 15:00
Pauze
Athene B/C (Dutch spoken)
15:00 - 16:30
Educational - Neoplastische Histiocytaire Aandoeningen: Uitdagingen en Vooruitzichten

Moderator:

Dr. Sanne Tonino

Casuistiek:

Dr. Sherida Woei-a-Jin

15:00 - 15:30
Pathologie: titel volgt

Spreker:

Dr. Konnie Hebeda

15:30 - 16:00
Kliniek: titel volgt

Spreker:

Dr. Jan van Laar

16:00 - 16:30
Translationeel: bredere impact van somatische DNA veranderingen in histiocyten

Spreker:

Dr. Astrid van Halteren

Foyer 2 (Dutch spoken)
15:00 - 16:30
Educational - Lange termijn effecten

Moderator:

Dr. Lotte van der Wagen

15:00 - 15:30
Presentatie 1
15:30 - 16:00
LEEF! Late effecten en follow-up na hematopoetische stamceltranplantatie

Spreker:

Dr. Anne de Pagter

16:00 - 16:30
Presentatie 3
Room 4/5
15:00 - 16:30
Benigne Abstracts (1)
15:00 - 15:15
1199: Exploring Biomarker Profiles in the Screening of Sickle Cell Nephropathy
Speaker:
Vera Hovin
15:15 - 15:30
1203: Prediction of readmission in patients with sickle cell disease
Speaker:
Caroline Vuong
15:30 - 15:45
1227: ATP release in patients with bleeding disorder of unknown cause
Speaker:
Amaury Monard
15:45 - 16:00
1267: Iron deficiency in HbSC disease

Speaker:

Marissa Traets

16:00 - 16:15
1220: Finding the hidden IgM: a study of complement-activating autoantibodies in AIHA
Speaker:
Femke Mulder
16:15 - 16:30
1231: Ex vivo glucose tracing in red blood cells from patients with rare hereditary anemias
Speaker:
Titine Ruiter
Room 8/9
15:00 - 16:30
Myeloid Abstracts (2)

Moderators:

 

15:00 - 15:15
1305: CEBPA-mutant AML
Speaker:
Bauke de Boer
15:15 - 15:30
1210: Single cell multi-omic analysis of NPM1-mutated AML
Speaker:
Onur Karakaslar
15:30 - 15:45
1256: Metformin sensitivity in AML is linked to metabolic shift towards lipid metabolism
Speaker:
Dominique Sternadt
15:45 - 16:00
1237: Genetic classification of AML by differential intergenic long noncoding RNA expression
Speaker:
Anne van der Grinten
16:00 - 16:15
1273: Persistence of IDH2 mutations in NPM1wt AML
Speaker:
Emma Boertjes
16:15 - 16:30
1322: Revumenib in pediatric R/R acute leukemia
Speaker:
Maaike Luesink
Room 8/9 (Dutch spoken)
15:00 - 16:30
Masterclass Beenmerg diagnostiek
Foyer
16:30 - 16:45
Pauze
Athene B/C (Dutch spoken)
16:45 - 17:45
How to treat - Immuungemedieerde cytopenie, anders dan anders

Moderator: 
Dr. Sophie Bernelot Moens

16:45 - 17:15
Als het niet gaat zoals het moet

Spreker: 

Dr. Hilde Kooistra

17:15 - 17:45
Als het niet is wat het lijkt

Spreker:

Dr. Dorothea Evers

Foyer 2 (Dutch spoken)
16:45 - 17:45
Educational -

Commissie zorgvernieuwing en Innovatie (NVvH)

Moderator: 
Prof. dr. Nicole Blijlevens

16:45 - 17:15
Vijf jaar Zorgvernieuwing & Innovatie commissie; wat is geleerd, wat is bereikt en welke plannen zijn er

Spreker:

Drs. Anton Tenzer

17:15 - 17:30
Keuzehulp CLL

Sprekers:

Dr. Sabina Kersting

Dr. Roel van Kampen

17:30 - 17:45
MPN PROM app

Sprekers:

Dr. Peter te Boekhorst samen met patient uit ontwikkelteam

 

Room 4/5
16:45 - 17:45
Meet the Expert Basaal (3)

Moderator:
Marcos Vidal Manrique, MSc

16:45 - 17:45
How to perform selective gene editing – CRISPR made easy
Speaker:
Dr. Iris Hagemans
Room 6/7
16:45 - 17:45
Immunology Abstracts (3)
16:45 - 17:00
1328: Finding and validating new targets for immunotherapy against malignant progenitor T cells

Speaker:

Jorik van Rijn

17:00 - 17:15
1325: Whole-body CD8+ T cell PET imaging in patients with DLBCL before and during anti-CD19 CAR

Speaker:

Jaap van Doesum

17:15 - 17:30
1292: Treatment with immunochemotherapy decreases the metabolic fitness of CD19 CAR T-cells in D

Speaker:

Tessa Knol

17:30 - 17:45
1324: Population-based external validation of the CAR-HEMATOTOX score to predict CAR T-cell rela

Speaker:

Kylie Keijzer

Room 8/9 (Dutch spoken)
16:45 - 17:45
Masterclass Beenmerg diagnostiek vervolg


NB: deel 2 van de masterclass kan alleen worden gevolgd met een registratie voor deel 1.

Athene B/C
17:45 - 18:00
Nominee of the Jaap Steenbergen stipendium: ceremony and presentation
Athene B/C
18:00 - 18:45
Keynote speaker: Prof. dr. Marc Raaijmakers

Moderator: Prof. dr. Joop Jansen

Foyer
18:45 - 20:30
Buffet (only applicable for employees in hospitals and research institutes)
Athene B/C (Dutch spoken)
09:00 - 10:30
Educational Transplantatie sessie

Moderators:
Prof. dr. Jurgen Kuball
Dr. Stijn Halkes 

09:00 - 09:45
Debat 1: AlloSCT bij TP53/complex karyotype AML

Sprekers:

Dr. Janine van Elssen

Dr. Carolien Woolthuis 

09:45 - 10:30
Debat 2: Upfront alloSCT bij hoog risico MDS

Sprekers:

Dr. Canan Alhan 

Dr. Michel van Gelder

Room 4/5
09:00 - 10:30
Clinical Abstracts (3)

Moderators:

Laurens Nieuwenhuizen

Sarah Schep

09:00 - 09:15
1284: Real-World bispecific antibody therapy for RRMM: Insights from Dutch Nationwide registry
Speaker:
Marjolein Appelman
09:15 - 09:30
1230: Favorable outcome of abbreviated R-CHOP in PTL patients
Speaker:
Diana Al-Sarayfi
09:30 - 09:45
1321: Myocardial dysfunction in survivors of diffuse large B-cell lymphoma and a sibling control
Speaker:
Suzanne Neppelenbroek
09:45 - 10:00
1271: Clinical Characteristics and Outcomes of Untreated AL-amyloidosis Patients in the Netherla
Speaker:
Flores Weverling
10:00 - 10:15
1201: Oral foci and hospital stay after HCT
Speaker:
Marie-Charlotte Huysmans
10:15 - 10:30
1270: One year of ODAP sutimlimab in cold agglutinin disease
Speaker:
Kathelijn Verdeyen
Room 6/7
09:00 - 10:30
Myeloid Abstracts (3)

Moderators:

 

09:00 - 09:15
1317: iPSC-derived hematopoietic cells represent an adequate disease model to study anemia and t
Speaker:
Teun Slijkerman
09:15 - 09:30
1319: RPS26-deficiency in Diamond-Blackfan Anemia syndrome represents a subset of disease.
Speaker:
Marien van der Stel
09:30 - 09:45
1318: B- and NK-cells in pediatric aplastic anemia
Speaker:
Alex Mohseny
09:45 - 10:00
1303: CD34+CD38- LSC in non-intensive AML
Speaker:
Tom Reuvekamp
10:00 - 10:15
1276: Why do stem cells fail? Single-cell analysis of pediatric myelodysplastic syndromes
Speaker:
Patrycja Fryzik
10:15 - 10:30
1191: Modelling hematopoiesis in rats – innovative means to study ineffective hematopoiesis
Speaker:
Santhe van der Meulen
Room 8/9 (Dutch spoken)
09:00 - 10:30
Educational Benigne hematologie; hemostase

Moderators:

Dr. Saskia Schols

Dr. Gerard Jansen

09:00 - 09:30
Update on VWD
Speaker:
Dr. Ferdows Atiq
09:30 - 10:00
Nieuwe behandelingen voor hemofilie
Speaker:
Prof. dr. Karina Meijer
10:00 - 10:30
Hevig menstrueel bloedverlies bij patiënten met een stollingsstoornis
Speaker:
Dr. Karin van Galen
Foyer
10:30 - 10:45
Pauze
Athene A (Dutch spoken)
10:45 - 12:15
Educational - MGUS en Amyloidose

Moderators:

Dr. Josien Regelink

Drs. Kaz Groen

10:45 - 11:15
MGUS poli in de praktijk, is er een rol voor vroegdetectie?

Spreker:

Prof. dr. Monique Minnema

11:15 - 11:45
POEMS-syndroom: uitdagingen bij diagnose en behandeling

Spreker:

Dr. Ruth Wester

11:45 - 12:15
Behandeling AL amyloidose

Spreker:

Dr. Wilfried Roeloffzen

Athene B/C (Dutch spoken)
10:45 - 12:15
How to treat - Aplastische anemie / PNH / BMF

Moderator:

Dr. Stijn Halkes

10:45 - 11:15
Aplastische Anemie

Speker:

Dr. Jennifer Tjon

11:15 - 11:45
PNH

Spreker:

Dr. Saskia Langemeijer

11:45 - 12:15
Genetische predispositie voor myeloide maligniteiten

Spreker:

Dr. Laura van Hussen - Daenen

Room 4/5
10:45 - 12:15
Immunology Abstracts (4)
10:45 - 11:00
1204: TIL products generated from bone marrow metastases for neuroblastoma patients as potential

Speaker:

Suzanne Castenmiller

11:00 - 11:15
1233: Targeting tumor metabolism using affinity enhanced engineered T cells and bispecifics

Speaker:

Mara Nicolasen

11:15 - 11:30
1307: T cell engineering

Speaker:

Brenda Raud

11:30 - 11:45
1243: Relevance of CCR5 in the efficacy of αβT cell based immunotherapies

Speaker:

Caroline Schwenzel

11:45 - 12:00
1246: T cell receptor gene therapy targeting mutant NPM1 on acute myeloid leukemia

Speaker:

Eva Argiro

12:00 - 12:15
1234: Dual role of heme oxygenase-1 in mice and men with acute graft-versus-host disease

Speaker:

Myrddin Verheij

Room 6/7
10:45 - 12:15
Lymphoid Abstracts (3)
10:45 - 11:00
1222: Proteomic Profiling Using High-dimensional Multiplex Platforms
Speaker:
Martijn Kolijn
11:00 - 11:15
1258: TOX as a novel biomarker in T cell large granular lymphocytic leukemia
Speaker:
Arjan Diepstra
11:15 - 11:30
1205: Biochemical characterization of monoclonal IgM in WM
Speaker:
Wouter Verhaar
11:30 - 11:45
1229: Shared antigenic specificities of defined stereotyped CLL BCR subsets
Speaker:
Richard Bende
11:45 - 12:00
1313: Towards a new immunotherapeutic approach for exportin 1-mutated tumours

Speaker:

Niels van Heusden

12:00 - 12:15
1259: The Epstein Barr Virus miRNA landscape in Hodgkin lymphoma.
Speaker:
Nohora Rueda Forero
Room 8/9
10:45 - 12:15
Clinical Abstracts (4)

Moderator:

Josien Regelink

10:45 - 11:00
1300: Improved Efficacy with Response and MRD-guided Ibrutinib–Obinutuzumab (IO) Intensification
Speaker:
Mark-David Levin
11:00 - 11:15
1309: Lenalidomide with or without ESA in low risk MDS

Speaker:

Arjan van de Loosdrecht

11:15 - 11:30
1198: One test to measure them all!
Speaker:
Emma Urlings
11:30 - 11:45
1283: Treatment and outcome among patients with BPDCN in the Netherlands
Speaker:
Mirian Brink
11:45 - 12:00
1206: Patient-reported outcomes among patients treated with CAR T-cell therapy or bispecific T-c
Speaker:
Celine Broekhuizen
12:00 - 12:15
1254: RODEO: Prospective Multicenter Study on Patient-Guided TKI Dose Reduction in CML
Speaker:
Nienke Lokhorst
Foyer
12:15 - 13:30
Lunch en werkgroep vergaderingen
Athene B/C
13:30 - 14:15
Keynote speaker: Maria-Victoria Mateos, MD, PhD

Director of Myeloma Unit
University Hospital of Salamanca
Salamanca Spain

Moderator: Dr. Annemieke Broijl

Foyer
14:15 - 14:30
Pauze
Athene A (Dutch spoken)
14:30 - 16:00
Educational MDS
14:30 - 15:00
Presentatie 1
15:00 - 15:30
Presentatie 2
15:30 - 16:00
Presentatie 3
Athene B/C (Dutch spoken)
14:30 - 16:00
Educational AYA zorg breed / keuze zorg bij fertiliteit
14:30 - 15:00
Presentatie 1
15:00 - 15:30
Presentatie 2
15:30 - 16:00
Presentatie 3
Room 6/7
14:30 - 16:00
Lymphoid Abstracts (4)
14:30 - 14:45
1261: Watch-and-Wait outcomes in FL: Molecular, pathological, and clinical factors
Speaker:
Eva Hesius
14:45 - 15:00
1260: Clinical Correlation of Immune-Molecular Profiles in Primary Central Nervous System Lympho

Speaker:

Fleur de Groot

15:00 - 15:15
1326: ctDNA dynamics in RRDLBCL
Speaker:
Yuije Zhong
15:15 - 15:30
1244: Sequential treatment strategies to increase sensitivity of multiple myeloma cells to BCMA
Speaker:
Marta Cuenca
15:30 - 15:45
1255: Molecular Characterization of Gastrointestinal Diffuse Large B-Cell Lymphoma

Speaker:

Romée Jansen

15:45 - 16:00
1224: A multi-omics analysis of transformed nodal marginal zone lymhoma
Speaker:
Johanna Bult
Room 8/9
14:30 - 16:00
Myeloid abstracts (4)

Moderators:

 

14:30 - 14:45
1275: ETV6R369W disrupts megakaryopoiesis in a dominant negative manner
Speaker:
Huang Zhang
14:45 - 15:00
1301: Retrospective validation of computational MRD assessment in AML
Speaker:
Tim Mocking
15:00 - 15:15
1308: Myeloid progenitor populations in severe congenital neutropenia and stress myelopoiesis
Speaker:
Loulou Dubel
15:15 - 15:30
1269: Longitudinal dynamics of mutant TET2 clonal hematopoiesis
Speaker:
Maaike van Bergen
15:30 - 15:45
1312: Enhancer distance matters
Speaker:
Han Verhagen
15:45 - 16:00
1268: Relevance of MRD for intensively treated high-risk MDS patients
Speaker:
Coen Veenstra
Foyer
16:00 - 16:15
Pauze
Athene A (Dutch spoken)
16:15 - 17:45
Meet the Expert TMA

Moderators:

Prof. dr. Jaap Jan Zwaginga

Dr. Dorothea Evers

16:15 - 16:45
(Catastrofaal) antifosfolipiden syndroom – update anno 2025

Spreker:

Dr. Thijs van Mens

16:45 - 17:15
Congenitale TTP, ervaringen met recombinant ADAMTS-13

Spreker:

Dr. Tanja Netelenbos

17:15 - 17:45
TMA door de ogen van de nefroloog

Spreker:

Dr. Caroline Duineveld

Athene B/C (Dutch spoken)
16:15 - 17:45
How to treat - CML met nieuwe richtlijn

Moderator:
dr. Laura van Hussen- Daenen

 

16:15 - 16:45
Eerstelijnsbehandeling: de juiste TKI in de juiste dosering geleid door de nieuwe risicostratificatie

Spreker:

Dr. Peter Westerweel

16:45 - 17:15
Refractaire CML patiënt: keuzes in de ≥2e lijn en plaatsbepaling van asciminib

Spreker:

Dr. Saskia Klein

17:15 - 17:45
Behandelingsvrije remissie: nieuwe ontwikkelingen en de mogelijkheid van een 2e stoppoging

Spreker:

Dr. Jeroen Janssen

Room 8/9
16:15 - 17:45
Clinical Abstracts (5)

Moderators:

Vera Novotny

Claudia Ootjers

16:15 - 16:30
1253: Clinical benefit of routine periodic screening in low-grade B-cell malignancies
Speaker:
Jantina Kortleve
16:30 - 16:45
1293: Usage and Outcomes of Venetoclax for AML in the Netherlands
Speaker:
Benno Diekmann
16:45 - 17:00
1214: Real-world experience of immunochemotherapy in cold agglutinin disease/syndrome
Speaker:
Anne-Marie Becking
17:00 - 17:15
1209: Cost-Effectiveness of Frontline TKIs in Chronic Myeloid Leukemia Management
Speaker:
Sanne Metsemakers
17:15 - 17:30
1218: Breast implant-associated anaplastic large cell lymphoma in the Netherlands
Speaker:
Frederik Meeuwes
17:30 - 17:45
1250: First-line treatment for aplastic anemia in the Netherlands
Speaker:
Iris Lommerse
Athene B/C (Dutch spoken)
17:45 - 18:30
Keynote spreker: Michelle van Tongerloo

Marktwerking in de zorg | Kansenongelijkheid

Moderators: Dr. Laura van Hussen - Daenen en Dr. Suzanne van Dorp

Michelle van Tongerloo is huisarts en straatarts in Rotterdam.

Ze koppelt grote maatschappelijke vraagstukken aan de rauwe realiteit van haar spreekkamer

Foyer
19:00 - 20:30
Buffet (only applicabe for employees of hospitals and research institutes)
Athene A (Dutch spoken)
09:00 - 10:30
Tips en Tricks; Infecties en vaccinaties

Moderator:

Dr. Bram Goorhuis

 

09:00 - 09:30
Infectieproblematiek bij B-cel maligniteiten anno 2025

Spreker:

Dr. Margot Jak

09:30 - 10:30
Vaccinatie en preventie van infecties bij B-cel maligniteiten en hoe nu verder

Sprekers:

Dr. Inger Nijhof

Dr. Anke Bruns

Athene B/C (Dutch spoken)
09:00 - 10:30
Educational CLL

Moderators: 

Dr. Evert-Jan de Kruijf

Dr. Mark David Levin

09:00 - 10:00
Richtlijnbespreking met casuistiek

Sprekers:

Dr. Evert-Jan de Kruijf

Dr. Ilse Verpoorte

Dr. Ellen van der Spek

10:00 - 10:30
Kwaliteit van leven in CLL studies

Sprekers:

Dr. Lina van der Straten

Dr. Laura Eurelings

Foyer 2 (Dutch spoken)
09:00 - 10:30
Symposium Vereniging Hematologisch Laboratorium

Moderator:

Prof.dr.ing. Mathie Leers

 

09:00 - 09:30
CellWiki: naslag nieuwe stijl voor morfologie

Spreker:

Bob Smit

09:30 - 10:00
De inzet van machine learning in de diagnostiek van hemoglobinopathie

Spreker:

Steef Kurstjens

10:00 - 10:30
Digitale beenmergmorfologie-beoordeling

Spreker:

Jurgen Riedl

Foyer
10:30 - 10:45
Pauze
Athene A (Dutch spoken)
10:45 - 12:00
Educational Multipel Myeloom

Moderatoren:

Prof. dr. Sonja Zweegman en Dr. Annemiek Broijl

10:45 - 11:20
Hoog risico Multipel Myeloom

Risico in MM – hoog, hoger, hoogst
Spreker: Dr. Annemiek Broijl

Het nieuwe hoog; van techniek tot aan definitie
Spreker: Dr. Rimke Oostvogels

Zij leve hoog, maar hoe het langer te bereiken door nieuwe behandelingen Spreker: Prof. dr. Niels van de Donk

11:25 - 12:00
Supportive care Multipel Myeloom

Het nieuwe MM tijdperk – een lang, maar ook gelukkig leven
Spreker: Prof. dr. Sonja Zweegman

Bloedstollende therapie vereist een andere blik en behandeling
Spreker: Prof. dr. Karina Meijer

Therapie met bispecifieke antistoffen – dat smaakt naar minder maar ook naar meer Spreker: Dr. Janine van Elssen

Athene B/C (Dutch spoken)
10:45 - 12:00
Educational AI inpassingen bij hematologie

Moderator:

Dr. Peter Westerweel

10:45 - 12:00
Presentatie

Sprekers:

Prof. dr. ir. Geert Litjens

Dr. Ward van Beers

Foyer 2 (Dutch spoken)
10:45 - 12:00
Gezamenlijke sessie
10:45 - 12:00
Samen beslissen
Foyer
12:00 - 13:15
Lunch
Room 6/7
12:01 - 13:15
Algemene Leden Vergadering NVvH (inclusief lunchpakket )
Athene A (Dutch spoken)
13:15 - 14:45
Educational Diagnostiek bij MPN
13:15 - 13:45
Presentatie 1
13:45 - 14:15
Presentatie 2
14:15 - 14:45
Presentatie 3
Athene B/C
13:15 - 14:45
Educational - Toegang tot nieuwe middelen
13:15 - 13:45
Presentatie 1
13:45 - 14:15
Presentatie 2
14:15 - 14:45
Presentatie 3
Foyer 2 (Dutch spoken)
13:15 - 14:45
How to treat - Nieuwe richtlijn Hodgkin
13:15 - 13:45
Presentatie 1
13:45 - 14:15
Presentatie 2
14:15 - 14:45
Presentatie 3
Foyer
14:45 - 14:50
Loop pauze
Athene B/C (Dutch spoken)
14:50 - 15:45
Grand Round
Register
×